The updated situation in Italy and in the world Data on the pandemic in Italy. Today there are 5,335 new cases with 474,778 swabs and 33 deaths. The positivity rate is 1.1%, up from 0.85% yesterday. Hospitalizations (+49) and intensive (+2) are increasing. The currently positives are 78,644 in all, there is an increase of 1,866 cases since yesterday. Yesterday there were 4,866 positives with 570,335 swabs (rate at 0.85%) and 50 victims. Circular welcomes Aifa opinion, booster recall with Moderna Meanwhile, a circular signed by the director of prevention of the Ministry of Health Gianni Rezza, dictates the use of the Moderna vaccine as a "booster" dose as part of the anti-SARS-CoV-2 vaccination campaign / COVID-19, as indicated in an AIFA opinion yesterday. The "booster" doseSpikevax vaccine can be used at least six months after completion of the primary vaccine course, regardless of the previously used vaccine. The Technical Scientific Commission (Cts) of Aifa, having taken note of the decision of Ema (European Medicines Agency), had reiterated that, "as already established for the Pfizer booster dose, this opportunity should be offered as a priority to the subjects already indicated for the Comirnaty (Pfizer) vaccine ". The booster dose of the Spikevax vaccine will also be included in the list pursuant to Law 648/96 to allow its heterologous use.having noted the decision of Ema (European Medicines Agency) had reiterated that, "as already established for the Pfizer booster dose, this opportunity should be offered as a priority to subjects already indicated for the Comirnaty (Pfizer) vaccine". The booster dose of the Spikevax vaccine will also be included in the list pursuant to Law 648/96 to allow its heterologous use.having noted the decision of Ema (European Medicines Agency) had reiterated that, "as already established for the Pfizer booster dose, this opportunity should be offered as a priority to subjects already indicated for the Comirnaty (Pfizer) vaccine". The booster dose of the Spikevax vaccine will also be included in the list pursuant to Law 648/96 to allow its heterologous use.
Aifa: green light to booster with Moderna vaccine for adults
Coronavirus, 4,866 new cases and 50 victims
The virus restarts, the Rt index and incidence rising: the moderate risk regions rise to 18
Vaccines, Ema evaluates further data on the risk of myocarditis and pericarditis
Share
October 29, 2021 The updated situation in Italy and in the world
Data on the pandemic in Italy. Today there are 5,335 new cases with 474,778 swabs and 33 deaths. The positivity rate is 1.1%, up from 0.85% yesterday. Hospitalizations (+49) and intensive (+2) are increasing. The currently positives are 78,644 in all, there is an increase of 1,866 cases since yesterday.
Yesterday there were 4,866 positives with 570,335 swabs (rate at 0.85%) and 50 victims.
Circular welcomes Aifa opinion, booster recall with Moderna
Meanwhile, a circular signed by the director of prevention of the Ministry of Health Gianni Rezza, dictates the use of the Moderna vaccine as a "booster" dose as part of the anti-SARS-CoV-2 / COVID-19 vaccination campaign, as indicated in an opinion from AIFA yesterday. The booster dose of the Spikevax vaccine can be used at least six months after completion of the primary vaccine course, regardless of the previous vaccine used. The Technical Scientific Commission (Cts) of Aifa, having taken note of the decision of Ema (European Medicines Agency), had reiterated that, "as already established for the Pfizer booster dose, this opportunity should be offered as a priority to the subjects already indicated for the Comirnaty (Pfizer) vaccine ".The booster dose of the Spikevax vaccine will also be included in the list pursuant to Law 648/96 to allow its heterologous use.
